IS
IS · IS · IS-EU/1/22/1631/001
Breyanzi
ATC L01XL08
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerBristol-Myers Squibb Pharma EEIG*
CountryIS (IS)
ATC codeL01XL08
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Innrennslislyf, ördreifa",
"source": "lyfjastofnun",
"atc_raw": "L01XL08",
"marketed": false,
"strength": "5,1 to 322 x 10^6 frumur",
"ma_number": "EU/1/22/1631/001",
"substance": "Lisocabtagene maraleucel",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "44655"
}Related drugs
Other records sharing ATC code L01XL08.
- DKBreyanziBristol-Myers Squibb Pharma EEIG
- PLBreyanziBristol-Myers Squibb Pharma EEIG
- NOBreyanziBristol-Myers Squibb Pharma EEIG
- BEBreyanziBristol-Myers Squibb Pharma
- FIBreyanziBristol-Myers Squibb Pharma EEIG
- CABREYANZIBRISTOL-MYERS SQUIBB CANADA
- CZBREYANZIBristol-Myers Squibb Pharma EEIG, Dublin
- NLBreyanzi >= 5.1 x 10^6 cellen [CD4 component], suspensie voor injectieCelgene Europe B.V.
Access this data programmatically
Query Breyanzi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.